rs1047727032

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001281740.3(FHOD3):​c.113C>T​(p.Ala38Val) variant causes a missense change. The variant allele was found at a frequency of 0.000000707 in 1,413,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

FHOD3
NM_001281740.3 missense

Scores

2
4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.59

Publications

0 publications found
Variant links:
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
FHOD3 Gene-Disease associations (from GenCC):
  • cardiomyopathy, familial hypertrophic, 28
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24916878).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHOD3NM_001281740.3 linkc.113C>T p.Ala38Val missense_variant Exon 1 of 29 ENST00000590592.6 NP_001268669.1 Q2V2M9-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHOD3ENST00000590592.6 linkc.113C>T p.Ala38Val missense_variant Exon 1 of 29 1 NM_001281740.3 ENSP00000466937.1 Q2V2M9-4
FHOD3ENST00000257209.8 linkc.113C>T p.Ala38Val missense_variant Exon 1 of 25 1 ENSP00000257209.3 Q2V2M9-3
FHOD3ENST00000359247.8 linkc.113C>T p.Ala38Val missense_variant Exon 1 of 24 1 ENSP00000352186.3 Q2V2M9-1
FHOD3ENST00000589114.5 linkn.232C>T non_coding_transcript_exon_variant Exon 1 of 14 2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.07e-7
AC:
1
AN:
1413738
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
699692
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30974
American (AMR)
AF:
0.00
AC:
0
AN:
38610
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25044
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36156
South Asian (SAS)
AF:
0.0000125
AC:
1
AN:
79698
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49900
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5684
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1089138
Other (OTH)
AF:
0.00
AC:
0
AN:
58534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
May 01, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.113C>T (p.A38V) alteration is located in exon 1 (coding exon 1) of the FHOD3 gene. This alteration results from a C to T substitution at nucleotide position 113, causing the alanine (A) at amino acid position 38 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.59
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.017
.;.;T
Eigen
Benign
0.12
Eigen_PC
Benign
0.17
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.96
D;D;D
M_CAP
Pathogenic
0.53
D
MetaRNN
Benign
0.25
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N;N;N
PhyloP100
3.6
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-1.4
N;.;N
REVEL
Benign
0.11
Sift
Uncertain
0.017
D;.;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
0.95
P;.;B
Vest4
0.064
MutPred
0.30
Loss of helix (P = 0.079);Loss of helix (P = 0.079);Loss of helix (P = 0.079);
MVP
0.068
MPC
2.6
ClinPred
0.85
D
GERP RS
3.2
PromoterAI
-0.013
Neutral
Varity_R
0.15
gMVP
0.34
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1047727032; hg19: chr18-33877911; API